{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Preoperative Inorganic Nitrate in Cardiac Surgery"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "single-centre, randomised, double-blind, placebo-controlled trial included 82 patients"
      },
      "Participants": {
        "score": 2,
        "evidence": "Conducted at a Swedish hospital, this single-centre, randomised, double-blind, placebo-controlled trial included 82 patients aged 18-80 years scheduled for coronary artery bypass grafting with cardiopulmonary bypass. Exclusion criteria encompassed pregnancy, re-do surgery, and significant organ disease."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were randomised in blocks of four to receive either oral sodium nitrate (700 mg\u00d72) or placebo (NaCl) before surgery."
      },
      "Objective": {
        "score": 1,
        "evidence": "This trial assessed whether preoperative inorganic nitrate could reduce troponin T release and other organ injury biomarkers in patients undergoing cardiac surgery."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was troponin T release over 72 hours postoperatively."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation and allocation were concealed"
      },
      "Blinding": {
        "score": 3,
        "evidence": "all participants, clinicians, and outcome assessors were blinded"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Ninety-five patients were randomised, with 42 in the placebo group and 40 in the nitrate group completing the study."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "Ninety-five patients were randomised, with 42 in the placebo group and 40 in the nitrate group completing the study."
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "The 72-hour troponin T release showed no significant difference between groups (p=0.19)."
      },
      "Harms": {
        "score": 1,
        "evidence": "no significant differences in adverse events between groups."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NCT01348971."
      },
      "Funding": {
        "score": 1,
        "evidence": "Funding: The trial was supported by institutional grants."
      }
    },
    "total_score": 22,
    "max_score": 25
  },
  "model": "gpt-4o"
}